Bonalive Biomaterials
Jimmy Lucchesi has extensive experience in the biomaterials sector, currently serving as Chief Technology Officer at BonAlive Biomaterials since June 2017. Prior to this role, Jimmy held positions as Chief Operating Officer and Research & Development Manager at BonAlive Biomaterials Ltd. from March 2013 to May 2017 and from January 2010 to February 2013, respectively. Earlier in Jimmy's career, significant roles included Market Analyst at Vivoxid Ltd. in Turku, Finland from June 2006 to January 2010, and Research Scientist at both Unicrop Ltd. in Helsinki from April 2002 to August 2005 and at the University of Helsinki and the Institute of Biotechnology from June 1995 to March 2002. Jimmy holds a degree from Metropolia University of Applied Sciences, obtained between 1992 and 1996.
This person is not in any teams
This person is not in any offices
Bonalive Biomaterials
As the world seeks answers to the growing threat of antibiotic resistance, Bonalive represents a new standard in patient care. Evolving at the intersection of technology and human biology, our Smart Healing™ technologies reduce antibiotic treatments and enable a better quality of life for patients. Smart Healing™ encompasses our commitment to our customers. It defines everything we do, in providing patients and surgeons well-proven and safe bone regenerative products in orthopedics, trauma, spine, septic bone and ear surgery. It's time to heal smarter. #SmartHealing For indications, contraindications, warnings and precautions related to Bonalive® products refer to the IFU within the product package. This site is not intended for US customers.